Sophie Lanzkron, MD, MHS, is a hematologist and professor specializing in classical hematology. She serves as Division Director of the Cardeza Center and Division of Hematology at Thomas Jefferson University’s Sidney Kimmel Medical College, where she is also the Leandro M. Tocantins, MD - Farid I. Haurani, MD Director of the Cardeza Foundation for Hematologic Research, Professor of Medicine, and Leader for Classical Hematology in the Department of Medicine. Her clinical focus includes adult benign hematology, care delivery for inherited and chronic blood disorders, and improving access and transitions across hematology care systems. Dr. Lanzkron is an internationally recognized physician-scientist whose research centers on health services research in benign hematology, equitable models of care and patient-centered outcomes, and clinical trial standardization and patient engagement. She has led major national initiatives in data-driven care improvement and clinician education, and is widely known for her commitment to mentoring the next generation of hematologists. Her achievements include the ASH Mentor Award in Clinical Science, the Dr. Susan M. MacDonald Sponsorship Award, and national leadership roles as co-founder and vice president of the National Alliance of Sickle Cell Centers, co-chair of the NIH Cure Sickle Cell Initiative Clinical Trial Sub-committee, and chair of the ASH Clinical Trial Network’s Patient Engagement Committee. She earned her MD from Albert Einstein College of Medicine, completed her internal medicine residency at the University of Maryland Medical System, and pursued fellowship training in hematology at the Johns Hopkins University School of Medicine. She also received a Master of Health Science from the Johns Hopkins Bloomberg School of Public Health.
Professor
Medical School
1987 – 1991
Residency
1991 – 1994
Fellowship
1994 – 1997